0001415889-18-000047.txt : 20180112
0001415889-18-000047.hdr.sgml : 20180112
20180112165643
ACCESSION NUMBER: 0001415889-18-000047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180110
FILED AS OF DATE: 20180112
DATE AS OF CHANGE: 20180112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jaksch Frank L Jr
CENTRAL INDEX KEY: 0001437237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37752
FILM NUMBER: 18526480
MAIL ADDRESS:
STREET 1: 10005 MUIRLANDS BOULEVARD
STREET 2: SUITE G FIRST FLOOR
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChromaDex Corp.
CENTRAL INDEX KEY: 0001386570
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 262940963
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10005 MUIRLANDS BLVD.
STREET 2: STE. G, FIRST FLOOR
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-419-0288
MAIL ADDRESS:
STREET 1: 10005 MUIRLANDS BLVD.
STREET 2: STE. G, FIRST FLOOR
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: CODY RESOURCES, INC.
DATE OF NAME CHANGE: 20070112
4
1
form4-01122018_010129.xml
X0306
4
2018-01-10
0001386570
ChromaDex Corp.
CDXC
0001437237
Jaksch Frank L Jr
10005 MUIRLANDS BLVD.
SUITE G
IRVINE
CA
92618
true
true
false
false
CEO
Common Stock
2018-01-10
4
M
0
22130
4.5
A
223687
D
Common Stock
2018-01-10
4
S
0
22130
6.52
D
201557
D
Common Stock
2018-01-11
4
M
0
6249
4.5
A
207806
D
Common Stock
2018-01-11
4
S
0
6249
6.5
D
201557
D
Common Stock
2075052
I
By Black Sheep, FLP
Employee Stock Options (right to buy)
4.50
2018-01-10
4
M
0
22130
0
D
2009-04-21
2018-04-21
Common Stock
22130
202804
D
Employee Stock Options (right to buy)
4.50
2018-01-11
4
M
0
6249
0
D
2009-04-21
2018-04-21
Common Stock
6249
196555
D
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on November 17, 2017. The options exercised and sold were scheduled to expire on April 21, 2018 and Mr. Jaksch sold the shares so that the proceeds can be used to cover the exercise payment and applicable withholding taxes due.
The weighted average sale price for the transaction reported was $6.52, and the range of prices were between $6.50 and $6.58. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
/s/ Frank Jaksch
2018-01-12